These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 31149866)

  • 41. Diagnostic performance of loss of nigral hyperintensity on susceptibility-weighted imaging in parkinsonism: an updated meta-analysis.
    Kim PH; Lee DH; Suh CH; Kim M; Shim WH; Kim SJ
    Eur Radiol; 2021 Aug; 31(8):6342-6352. PubMed ID: 33449183
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Fast 3 T nigral hyperintensity magnetic resonance imaging in Parkinson's disease.
    Hernadi G; Pinter D; Nagy SA; Orsi G; Komoly S; Janszky J; Kovacs N; Perlaki G
    Sci Rep; 2021 Jan; 11(1):1179. PubMed ID: 33441889
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The clinical application of nigrosome 1 detection on high-resolution susceptibility-weighted imaging in the evaluation of suspected Parkinsonism: The real-world performance and pitfalls.
    Lee J; Lee AL; Park JH; Moon JE; Park JM; Kim SJ; Chang KH
    PLoS One; 2020; 15(4):e0231010. PubMed ID: 32240236
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Nigrosome 1 imaging: technical considerations and clinical applications.
    Kim EY; Sung YH; Lee J
    Br J Radiol; 2019 Sep; 92(1101):20180842. PubMed ID: 31067082
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Hyperechogenicity of substantia nigra for differential diagnosis of Parkinson's disease: A meta-analysis.
    Shafieesabet A; Fereshtehnejad SM; Shafieesabet A; Delbari A; Baradaran HR; Postuma RB; Lökk J
    Parkinsonism Relat Disord; 2017 Sep; 42():1-11. PubMed ID: 28647434
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Accuracy of nigrosome-1 detection to discriminate patients with Parkinson's disease and essential tremor.
    Perez Akly MS; Stefani CV; Ciancaglini L; Bestoso JS; Funes JA; Bauso DJ; Besada CH
    Neuroradiol J; 2019 Dec; 32(6):395-400. PubMed ID: 31149866
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A preliminary attempt to visualize nigrosome 1 in the substantia nigra for Parkinson's disease at 3T: An efficient susceptibility map-weighted imaging (SMWI) with quantitative susceptibility mapping using deep neural network (QSMnet).
    Jo M; Oh SH
    Med Phys; 2020 Mar; 47(3):1151-1160. PubMed ID: 31883389
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Imaging of nigrosome 1 in substantia nigra at 3T using multiecho susceptibility map-weighted imaging (SMWI).
    Nam Y; Gho SM; Kim DH; Kim EY; Lee J
    J Magn Reson Imaging; 2017 Aug; 46(2):528-536. PubMed ID: 27859983
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Imaging the Nigrosome 1 in the substantia nigra using susceptibility weighted imaging and quantitative susceptibility mapping: An application to Parkinson's disease.
    Cheng Z; He N; Huang P; Li Y; Tang R; Sethi SK; Ghassaban K; Yerramsetty KK; Palutla VK; Chen S; Yan F; Haacke EM
    Neuroimage Clin; 2020; 25():102103. PubMed ID: 31869769
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Magnetic resonance imaging evaluation of nigrosome 1 and neuromelanin can assist Parkinson's disease diagnosis, but requires an expert neuroradiologist.
    De Pietro Franco Zorzenon C; Almeida Antônio Bienes GH; Duarte Alves E; Tobaru Tibana LA; Carrete Júnior H; Ballalai Ferraz H
    Parkinsonism Relat Disord; 2021 Feb; 83():8-12. PubMed ID: 33418131
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Substantia nigra hyperechogenicity and Parkinson's disease risk in patients with essential tremor.
    Sprenger FS; Wurster I; Seppi K; Stockner H; Scherfler C; Sojer M; Schmidauer C; Berg D; Poewe W
    Mov Disord; 2016 Apr; 31(4):579-83. PubMed ID: 26893155
    [TBL] [Abstract][Full Text] [Related]  

  • 52. MR findings in the substantia nigra on phase difference enhanced imaging in neurodegenerative parkinsonism.
    Sugiyama A; Sato N; Kimura Y; Ota M; Maekawa T; Sone D; Enokizono M; Murata M; Matsuda H; Kuwabara S
    Parkinsonism Relat Disord; 2018 Mar; 48():10-16. PubMed ID: 29279191
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Abnormalities of regional brain function in Parkinson's disease: a meta-analysis of resting state functional magnetic resonance imaging studies.
    Pan P; Zhang Y; Liu Y; Zhang H; Guan D; Xu Y
    Sci Rep; 2017 Jan; 7():40469. PubMed ID: 28079169
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Nigrosome-1 on Susceptibility Weighted Imaging to Differentiate Parkinson's Disease From Atypical Parkinsonism: An In Vivo and Ex Vivo Pilot Study.
    Meijer FJ; Steens SC; van Rumund A; van Cappellen van Walsum AM; Küsters B; Esselink RA; Verbeek MM; Bloem BR; Goraj B
    Pol J Radiol; 2016; 81():363-9. PubMed ID: 27559425
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Early- and late-onset essential tremor patients represent clinically distinct subgroups.
    Hopfner F; Ahlf A; Lorenz D; Klebe S; Zeuner KE; Kuhlenbäumer G; Deuschl G
    Mov Disord; 2016 Oct; 31(10):1560-1566. PubMed ID: 27384030
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Loss of Nigral Hyperintensity on 3 Tesla MRI of Parkinsonism: Comparison With (123) I-FP-CIT SPECT.
    Bae YJ; Kim JM; Kim E; Lee KM; Kang SY; Park HS; Kim KJ; Kim YE; Oh ES; Yun JY; Kim JS; Jeong HJ; Jeon B; Kim SE
    Mov Disord; 2016 May; 31(5):684-92. PubMed ID: 26990970
    [TBL] [Abstract][Full Text] [Related]  

  • 57.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 58.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.